Find the latest Scibase Holding AB (SCIB.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.
SciBase Holding AB is a Sweden-based company engaged in the medical equipment industry. The Company specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma.
Nevisense is based on substantial research and has achieved excellent results in the largest clinical study ever conducted on the detection of malignant melanoma. SCIB | Complete SciBase Holding AB stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Köp aktier i Scibase Holding - enkelt och billigt hos Avanza Bank. Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Sweden AB. Med ”SEK” avses SciBase Holding AB (publ) är ett svenskt publikt aktiebolag som registrerades den 18 december 2008 och vars verksamhet bedrivs enligt svensk rätt.
Legal documents (Swedish) Vator Secur 3 Aug 2016 Ginolis's successful partnership with SciBase reaches final milestone. Ginolis has SciBase AB is a Swedish medical technology company, 1 day ago PRNewswire/ -- The shareholders in SciBase Holding AB (publ), reg. by Euroclear Sweden AB (the Swedish Central Securities Depository SciLifeLab has been created by the coordinated effort of four universities in Stockholm and Uppsala: Stockholm University, Karolinska Institutet, KTH Royal Institute Welcome to SciBase! A study in Machine Learning, Repository and the first complete Web-Dictionary of Scholastic Information System. slider image 5 feb 2021 SciBase AB is a global medical technology company based in Stockholm, Sweden that develops unique point-of-care devices for the 16 Sep 2020 STOCKHOLM, Sept. SciBase AB is a Swedish medical technology company, Professor at The Karolinska Institute in Stockholm, Sweden.
Coming events. 2021-05-13.
Scibase Holding AB. Organisationsnummer 556773-4768. Namnändringar och notering på lista. År. Kommentarer. Aktien är noterad på First North. 2015.
16.30 i Setterwalls Advokatbyrås lokaler med adress Sturegatan 10 i Stockholm. to, okt 26, 2017 21:01 CET. Aktieägarna i SciBase Holding AB (publ), org. nr 556773-4768 (”Bolaget”) kallas härmed till extra bolagsstämma onsdagen den 15 november 2017 kl.
Hemcheck Sweden AB har idag anställt David Melin som ny CTO i som Director Product Development på SciBase där han varit i över 8 år.
Phone, : + Hansa Medical, Hanza Holding, Header Compression Sweden Holding AB, Heathrow, Heba B, Helena Helmersson, Heliospectra, Hemcheck Sweden AB SciBase genomför första leveransen av Nevisense View. Redaktionen dermatoskopi. Idag lämnar det första nya instrumentet SciBase och den första Nevisense View levereras till Belgien. 111 22 Stockholm, Sweden.
556773-4768 (the "Company"), are hereby given notice to attend the annual general meeting at 2:00
Currently at an assignment abroad, Board member of companies including Apoteket AB, Getinge AB, European Sperm bank A/S, Sophiahemmet AB, WeMind AB, and Life Clean AB. Consultant and Advisor. Holdings in SciBase: Holder of 0 shares. Independence Barbro is independent in relation to the Company, management and the Company’s major shareholders. Contact Email info@scibase.com Phone Number 46 8 41 06 20 00 Founded in 1998, SciBase AB is a Swedish medical technology company, headquartered in Stockholm, that has developed a unique point of care device for the accurate detection of malignant melanoma. SciBase AB is a global medical technology company based in Stockholm, Sweden that develops unique point-of-care devices for the evaluation of skin disorders such as skin cancer and atopic
SciBase AB is a global medical technology company based in Stockholm, Sweden that develops unique point-of-care devices for the evaluation of skin disorders such as skin cancer and atopic
Description. SciBase AB is a Swedish medical technology company, headquartered in Stockholm that has developed and sells a unique point-of-care device for evaluation of skin disorders such as skin cancer and atopic dermatitis.
Turk lirasi 50000
Annual General Meeting 2021. 2021-08-19. Interim Report Q2 2021. 2021-11-11. The shareholders in SciBase Holding AB (publ), reg.
”uniträtter”) och fem (5) uniträtter berättigar till teckning av en (1) unit. Varje unit består av en (1) aktie och en (1) teckningsoption. 1 dag sedan · The shareholders in SciBase Holding AB (publ), reg.
Tunga hjärtslag
SciBase AB,556777-3899 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, varumärken, adress mm för SciBase AB
Anmälan görs per post till SciBase Holding AB (publ), Box 3337, 103 67 Stockholm, per e-post till info@scibase.com eller per telefon till 08-410 620 00.
Aktieägarna i SciBase Holding AB, org. nr 556773-4768, (nedan införd i den av Euroclear Sweden AB förda aktieboken tisdagen den 10 maj
10.00 i Setterwalls Advokatbyrås lokaler med adress Sturegatan 2020-10-21 11:00:00 SciBase Holding AB announces the outcome of the exercise of warrants of series TO1-2,85% | 1,12 MSEK 2020-10-02 08:00:00 Lösenpris fastställt avseende teckningsoptioner av serie TO1 i SciBase Holding AB, där teckningsperioden inleds den 5 oktober 2020 +0,24% | 1,29 MSEK 2019-05-16 · Bulletin from annual general meeting of SciBase Holding AB (publ) on 16 May 2019 Thu, May 16, 2019 19:00 CET. At the annual general meeting of SciBase Holding AB (publ) on 16 May 2019 in Stockholm the shareholders adopted the below resolutions. SciBase Holding AB (publ) höll extra bolagsstämma den 15 november 2017 i Stockholm. Nedan följer en sammanfattning av de beslut som fattades vid stämman.
Coordinate, : 59.36053, 17.97063. What3Words, : loading.. Phone, : + Hansa Medical, Hanza Holding, Header Compression Sweden Holding AB, Heathrow, Heba B, Helena Helmersson, Heliospectra, Hemcheck Sweden AB SciBase genomför första leveransen av Nevisense View. Redaktionen dermatoskopi. Idag lämnar det första nya instrumentet SciBase och den första Nevisense View levereras till Belgien.